Shanghai LabEx Biotechnology Co., Ltd. announced that it will receive CNY 15 million in an equity round of funding from returning investor Shanghai Universal Biotech Co.,Ltd. on February 20, 2022, The transaction was approved by the board of directors of the investor at its 3rd session of 3rd directorate and the 2nd session of 3rd supervisory board. Post to the closing, the registered capital of the company will increase from CNY 5 million to CNY 20 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.49 CNY | -0.52% | -2.30% | -25.85% |
1st Jan change | Capi. | |
---|---|---|
-25.85% | 341M | |
+23.92% | 74.58B | |
-2.46% | 23.95B | |
+10.52% | 8.52B | |
+6.60% | 8.55B | |
-21.71% | 7.85B | |
+11.90% | 5.18B | |
+2.27% | 4.17B | |
-4.23% | 4.06B | |
+5.42% | 3.89B |
- Stock Market
- Equities
- 301166 Stock
- News Shanghai Universal Biotech Co.,Ltd.
- Shanghai LabEx Biotechnology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Shanghai Universal Biotech Co.,Ltd.